Transformation of the Pharmaceutical Industry Post-Pandemic
The reason for speeding up pharmacovigilance was well highlighted during the pandemic, that was propelled by vaccine research and delivery
Greater adoption of digital technologies for drug development and clinical trials
the focus has evidently shifted towards imparting richer in-hand experience
in the industry.
Increased investment in supply chain resilience
The pharmaceuticals industry is also following this path to advance its operations, deliveries and research and development.
For more such content